A study to evaluate demographic and clinical characteristics of osteoporosis patients treated with Denosumab and their degree of compliance and possible causes of treatment cessation
Latest Information Update: 02 Jul 2020
At a glance
- Drugs Denosumab (Primary)
- Indications Fracture; Osteoporosis; Vertebral fracture
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 02 Jul 2020 New trial record
- 06 Jun 2020 Results presented at the 21st Annual Congress of the European League Against Rheumatism